Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
The Itch of Cancer Therapeutics: An Oncodermatology Perspective
Description
In the talk by Mariola Couture, she highlights the significant impact of cancer and its therapies on patient life, emphasizing that a considerable portion of the population will be diagnosed with cancer. Couture discusses the advancement of cancer treatments following the establishment of the National Cancer Act in 1971, leading to improved survival rates in both solid and hematologic cancers. Despite these advancements, cancer survivors often face various late effects, particularly dermatologic conditions exacerbated by systemic therapies such as chemotherapy and immunotherapy. Pruritus, or itching, emerges as a common yet underreported issue among cancer patients, affecting their quality of life, with many not receiving adequate dermatological care. Couture presents findings from studies indicating accelerated aging of skin due to treatments, with implications for skin health post-cancer therapy. She underscores the need for specialized care from oncodermatologists to address these unique challenges faced by cancer survivors. Couture further discusses ongoing research, including the efficacy of biologic therapies for managing pruritus, and the pressing need for strategies to provide timely dermatological interventions to improve patient outcomes and quality of life. She concludes by encouraging dermatologists to be integral to the care of cancer patients, especially concerning managing treatment-related skin and pruritus issues.
View moreConclusions
- Many cancer patients develop skin-related side effects from therapies, significantly impacting their quality of life.
- Pruritus is common in cancer survivors, with approximately 40% experiencing it as a long-term adverse effect.
- There is a need for better management of dermatological side effects associated with cancer treatments.
- Survivors report that skin conditions, including pruritus, can affect their physical and emotional well-being more significantly than gastrointestinal or neurological issues.
- Aging effects from cancer treatments can lead to premature aging of skin, hair, and nails in survivors, indicating the need for specialized skin care post-therapy.
- Biologic therapies targeting pruritus in cancer patients show promise, with many patients experiencing significant relief from symptoms.
- Preventative strategies, such as using moisturizers and systemic therapies, can reduce the severity of skin toxicities and improve patient outcomes in oncology.
- Increased recognition and referral to dermatologists for pruritic conditions are necessary in oncology to enhance patient care.
- Mukherjee S, 2010
- Holzel et al, Nat Rev Cancer 2013
- Scott et al, Nat Rev Drug Disc 2023
- Shapiro, NEJM 2018
- Gandhi et al, Supportive Care Cancer 2010
- Vallely et al, Supportive Care Cancer 2019
- Bhatia et al, Curr Oncol Reports 2022
- Sedrak et al, J Am Geriat Soc 2021
- Lacouture et al, San Antonio Breast Cancer Symp 2018
- Lacouture, Nat Rev Cancer 2006
- Lacouture et al, J Clin Oncol 2010
- Zhou et al, Cancer 2022
- Champiat et al, Ann Oncology 2016
- Coens et al, Lancet Oncol 2017
- Wolchok et al, New Engl J Med 2017
- Sznol et al, J Clin Oncol 2017
- Schmid et al, Eur J of Cancer 2016
- Michot et al, Eur J of Cancer 2016